YU48077B - Novi derivati benzimidazola i postupak njihove izrade - Google Patents

Novi derivati benzimidazola i postupak njihove izrade

Info

Publication number
YU48077B
YU48077B YU123691A YU123691A YU48077B YU 48077 B YU48077 B YU 48077B YU 123691 A YU123691 A YU 123691A YU 123691 A YU123691 A YU 123691A YU 48077 B YU48077 B YU 48077B
Authority
YU
Yugoslavia
Prior art keywords
radical
aryl
halogen
represent
values
Prior art date
Application number
YU123691A
Other languages
English (en)
Other versions
YU123691A (sh
Inventor
M.R. Cuberes-Altisent
J. Frigola-Constansa
J. Pares-Corominas
Original Assignee
Laboratorios Del Dr. Esteve S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Del Dr. Esteve S.A. filed Critical Laboratorios Del Dr. Esteve S.A.
Publication of YU123691A publication Critical patent/YU123691A/sh
Publication of YU48077B publication Critical patent/YU48077B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Novi derivati benzimidazola, naznačen time, što odgovaraju opštoj formuli I u kojoj: - R1 i R2, isti ili različiti, pretstavljaju vodonični atom, halogen, niži alkil radikal, hidroksi radikal, alkoksi radikal, alkil kar-boksilatni radikal, aril ili supstituisani aril radikal, - n može da ima vrednosti 0 ili 1, - m može da ima vrednosti 2 do 4, - X, Y, Z i W su isti ili različiti i čak grade deo istog prstena, aromatskog ili ne, pretstavljaju azotni atom ili ugljenični atom vezan za vodonični atom, za halogen ili za drugi alkil, aril, karboksialkil, karboksilni, hidroksilni, alkilhidroksi, sul-fonski, ili alkilsulfonski radikal. Prijava sadrži još 1 nezavisan i 1 zavisan zahtev.
YU123691A 1990-07-26 1991-07-12 Novi derivati benzimidazola i postupak njihove izrade YU48077B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9009563A FR2665161B1 (fr) 1990-07-26 1990-07-26 Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.

Publications (2)

Publication Number Publication Date
YU123691A YU123691A (sh) 1994-05-10
YU48077B true YU48077B (sh) 1997-01-08

Family

ID=9399131

Family Applications (1)

Application Number Title Priority Date Filing Date
YU123691A YU48077B (sh) 1990-07-26 1991-07-12 Novi derivati benzimidazola i postupak njihove izrade

Country Status (25)

Country Link
US (1) US5182280A (sh)
EP (1) EP0468884B1 (sh)
JP (1) JPH0832703B2 (sh)
KR (1) KR0183028B1 (sh)
CN (1) CN1030915C (sh)
AT (1) ATE131822T1 (sh)
AU (1) AU638857B2 (sh)
CA (1) CA2047880A1 (sh)
CZ (1) CZ280185B6 (sh)
DE (1) DE69115588T2 (sh)
DK (1) DK0468884T5 (sh)
ES (1) ES2038074B1 (sh)
FR (1) FR2665161B1 (sh)
GR (1) GR3019352T3 (sh)
HU (2) HU215109B (sh)
MX (1) MX9100377A (sh)
NO (1) NO178576C (sh)
NZ (1) NZ239104A (sh)
PL (1) PL167222B1 (sh)
PT (1) PT98409B (sh)
RO (1) RO109736B1 (sh)
RU (1) RU2024519C1 (sh)
TW (1) TW314518B (sh)
YU (1) YU48077B (sh)
ZA (1) ZA915839B (sh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.
FR2701260B1 (fr) * 1993-02-05 1995-05-05 Esteve Labor Dr Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments.
US5681954A (en) * 1993-05-14 1997-10-28 Daiichi Pharmaceutical Co., Ltd. Piperazine derivatives
JP3338913B2 (ja) * 1993-06-29 2002-10-28 大鵬薬品工業株式会社 テトラゾール誘導体
IL113472A0 (en) 1994-04-29 1995-07-31 Lilly Co Eli Non-peptidyl tachykinin receptor antogonists
FR2727865B1 (fr) * 1994-12-08 1997-07-18 Esteve Labor Dr Utilisation des derives de 2-(4-(azolybutyl)-piperazinyl- (methyl))-benzimidazole et analogues ainsi que de leurs sels, pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme
FR2731618B1 (fr) * 1995-03-14 1997-08-01 Esteve Labor Dr Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique
EP1165013A4 (en) * 1999-03-03 2002-08-07 Merck & Co Inc PRENYL PROTEIN TRANSFERASE INHIBITORS
US20020169166A1 (en) * 2001-03-09 2002-11-14 Cowart Marlon D. Benzimidazoles that are useful in treating sexual dysfunction
US7022728B2 (en) 2001-03-09 2006-04-04 Abbott Laboratories Benzimidazoles that are useful in treating male sexual dysfunction
US6960589B2 (en) 2001-03-09 2005-11-01 Abbott Laboratories Benzimidazoles that are useful in treating sexual dysfunction
WO2003101994A1 (en) * 2002-05-29 2003-12-11 Abbott Laboratories Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
US7057042B2 (en) 2002-05-29 2006-06-06 Abbott Laboratories Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
WO2004032861A2 (en) * 2002-10-11 2004-04-22 Bristol-Myers Squibb Company Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
CA2560896C (en) * 2004-03-25 2013-06-18 Janssen Pharmaceutica, N.V. Imidazole compounds
CN101089000B (zh) 2006-06-16 2011-01-05 北京大学 螺环哌嗪季铵盐类化合物及其制备方法和应用
ES2527545T3 (es) 2010-04-26 2015-01-26 Sumitomo Dainippon Pharma Co., Ltd. Un procedimiento de preparación de una sal de amonio cuaternario utilizando fosfato

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL272996A (sh) * 1960-12-28
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4179505A (en) * 1977-03-30 1979-12-18 Janssen Pharmaceutica N.V. 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
JPS59199679A (ja) * 1983-04-27 1984-11-12 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
DE3336409A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4684654A (en) * 1985-08-14 1987-08-04 American Cyanamid Company 3-heteroalkyl-2,4-quinzaolinediones
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
IT1226100B (it) * 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.

Also Published As

Publication number Publication date
HU912518D0 (en) 1992-01-28
US5182280A (en) 1993-01-26
EP0468884A1 (fr) 1992-01-29
CZ280185B6 (cs) 1995-11-15
NO912669L (no) 1992-01-27
ATE131822T1 (de) 1996-01-15
FR2665161B1 (fr) 1992-11-27
ES2038074B1 (es) 1994-02-01
ZA915839B (en) 1992-04-29
NO912669D0 (no) 1991-07-08
YU123691A (sh) 1994-05-10
NO178576C (no) 1996-04-24
NZ239104A (en) 1993-12-23
MX9100377A (es) 1992-02-28
ES2038074A1 (es) 1993-07-01
AU8128091A (en) 1992-01-30
JPH04234387A (ja) 1992-08-24
EP0468884B1 (fr) 1995-12-20
HU215109B (hu) 2000-04-28
PT98409B (pt) 1999-01-29
CN1030915C (zh) 1996-02-07
KR920002587A (ko) 1992-02-28
HU211599A9 (en) 1995-12-28
DK0468884T5 (da) 1996-09-30
PL291247A1 (en) 1992-03-09
CN1058404A (zh) 1992-02-05
PT98409A (pt) 1992-06-30
PL167222B1 (pl) 1995-08-31
GR3019352T3 (en) 1996-06-30
CS235191A3 (en) 1992-04-15
RU2024519C1 (ru) 1994-12-15
KR0183028B1 (ko) 1999-05-01
HUT58320A (en) 1992-02-28
JPH0832703B2 (ja) 1996-03-29
FR2665161A1 (fr) 1992-01-31
TW314518B (sh) 1997-09-01
AU638857B2 (en) 1993-07-08
DE69115588T2 (de) 1996-06-20
CA2047880A1 (fr) 1992-01-27
NO178576B (no) 1996-01-15
DE69115588D1 (de) 1996-02-01
RO109736B1 (ro) 1995-05-30

Similar Documents

Publication Publication Date Title
YU48077B (sh) Novi derivati benzimidazola i postupak njihove izrade
DE69132497D1 (de) Benzimidazolderivate, verfahren zu deren herstellung und deren anwendung
FI921473A (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
ES2043515A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-difenilmetilpiperazina.
DE3161640D1 (en) Propanol amine, derivatives, process for their preparation and medicines containing these compounds
NZ238431A (en) ((1-arylpyrrolidin-2-yl)methyl)piperazine derivatives; pharmaceutical compositions and preparatory processes